Mutares Juggles Two Major Deals as Dividend Does Little to Shore Up Share Price

Mutares shares fall 10% YTD despite €2 dividend; technicals bearish. Firm races to close Synthomer acquisition and NEM Energy sale by Q3 2026 to restore investor confidence.

Mutares shareholders received a €2.00 per share dividend earlier this month, but the payout has failed to lift a stock that continues to slide. The Munich-based holding company is now racing to close two significant transactions in the third quarter of 2026 — the acquisition of a Czech chemicals manufacturer and the sale of its NEM Energy Group — even as market sentiment remains subdued.

The shares ended Friday at €27.00, down 1.28% on the day and 5.59% over the week. Since the start of the year, the stock has lost nearly 10%, and it now sits 23.19% below its 52-week high of €35.15, reached back in January. Technical indicators reinforce the bearish tone: the price is 2.46% below its 50-day moving average of €27.68 and 6.40% under the 200-day average of €28.84. The relative strength index of 40.3 points to persistent selling pressure rather than any oversold bounce.

The dividend adjustment itself was always likely to weigh. The stock traded ex-dividend on July 6 and the €2.00 payout landed in accounts on July 8. Such mechanical moves typically depress the share price by the dividend amount, but the absence of any meaningful recovery since then underscores a broader lack of buying interest.

That weakness stands in contrast to the company’s strategic activity. In June, Mutares signed an agreement to acquire Synthomer a.s., a Czech producer of acrylate solutions, as the cornerstone of its new Chemicals & Materials segment. The target employs roughly 300 people and generated annual sales of around €110 million. The transaction, structured as a carve-out, is expected to close by the end of the third quarter of 2026. At the same time, Mutares has opened a new office in Houston to build its transaction pipeline in the US, a market that will be central to its medium-term ambitions through 2030.

On the exit side, the previously announced sale of NEM Energy Group to Hyundai Heavy Industries remains on track for completion in the same quarter, while media reports suggest Mutares is exploring both a direct sale and a potential initial public offering in Lisbon for its Portuguese holding Efacec, with JPMorgan advising on strategic options.

Management has reaffirmed its full-year guidance despite the share price weakness. Mutares expects consolidated revenue of €7.9 billion to €9.1 billion in 2026 and a holding-level net profit of €165 million to €200 million. The longer-term target of 25% annual growth in both revenue and net profit remains intact. The annual general meeting on July 3 passed all resolutions comfortably, including the appointment of PricewaterhouseCoopers Munich as the new auditor for the current financial year.

The half-year report, due on August 13, will provide the first concrete evidence of whether the US expansion and the Chemcials & Materials platform are already leaving a mark on the numbers. For now, Mutares is betting that the simultaneous closing of both the Synthomer acquisition and the NEM exit will give investors a clearer narrative — and hopefully a catalyst — in the months ahead.